Vai ai contenuti. | Spostati sulla navigazione | Spostati sulla ricerca | Vai al menu | Contatti | Accessibilità

| Crea un account

Proietti, Riccardo (2008) Pulmonary arterial hypertension. [Tesi di dottorato]

Full text disponibile come:

[img]
Anteprima
Documento PDF
1419Kb

Abstract (inglese)

Pulmonary arterial hypertension: correlation between severity of pathology and new markers of endothelail damage and repair


Statistiche Download - Aggiungi a RefWorks
Tipo di EPrint:Tesi di dottorato
Relatore:Thiene, Gaetano
Correlatore:Daliento, Luciano
Dottorato (corsi e scuole):Ciclo 20 > Scuole per il 20simo ciclo > SCIENZE MEDICHE, CLINICHE E SPERIMENTALI > SCIENZE CARDIOVASCOLARI
Data di deposito della tesi:31 Gennaio 2008
Anno di Pubblicazione:31 Gennaio 2008
Parole chiave (italiano / inglese):Pulmonary hypertension
Settori scientifico-disciplinari MIUR:Area 06 - Scienze mediche > MED/10 Malattie dell'apparato respiratorio
Struttura di riferimento:Dipartimenti > Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari
Codice ID:835
Depositato il:09 Ott 2008
Simple Metadata
Full Metadata
EndNote Format

Bibliografia

I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Simonneau G, Galié N, Rubin LJ et al. Clinical Classification of Pulmonary Hypertension. JACC 2004;43:5-12S. Cerca con Google

2. Budhiraja R, Tuder RM and Hassoun PM Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-165. Cerca con Google

3. M Humbert, NW Morrell, SL Archer, KR Stenmark, MR MacLean, IM Lang et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:12-23. Cerca con Google

4. Humbert M, Monti G, Fartoukh et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1628-1631. Cerca con Google

5. Dorfmuller P, Zarka V, Durand-Gasselin I et al. Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002;165:534-539. Cerca con Google

6. Fartoukh M, Emilie D, Le Gall C, et al. Chemokine macrophage inflammatory protein -1? mRNA expression in lung biopsy specimens of primari pulmonary hypertension. Chest 1998; 114 (1 suppl):50S-51S. Cerca con Google

7. Pinto RFA, de Lourdes Higuchi M, Aiello VD. Decreased numbers of T- lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts. Cardiovascular Pathology 2004.13.268- 275. Cerca con Google

8. Damas JK, Otterdal K, Yndestand A et al. Soluble CD40 ligand in Pulmonary Arterial Hypertension. Possible pathogenetic role of the interaction between platelets and endothelial cells. Circulation 2004;110:999-1005. Cerca con Google

9. Aubert J-K. Biochemical markers in the management of pulmonary hypertension. Swiss Med wkly 2005;135:43-49 Cerca con Google

10. SG Haworth. Role of the endothelium in pulmonary arterial hypertension. Vascular Pharmacology 45 (2006) 317-325. Cerca con Google

11. KR Stenmark, KA Fagan, MG Frid. Hypoxia-induced pulmonary vascular remodelling. Cellular and molecular mechanism. Cir Res 2006;99:675-691. Cerca con Google

12. Burke A and Virmani R. Mini-symposium:pulmonary pathologu. Evalutaion of pulmonary arterial hupertension in biopsies of the lung. Current Diagnostic Pathology. 2006;3:14-26. Cerca con Google

13. NJ Davie, JT Crossno, MG Frid. Hypoxia-induced pulmonary adventitial remodelling and neovascularization:contributor of progenitor cells. Am J Physiol Lung cell Mol Physiol 2004;286:668-678. Cerca con Google

14. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Bidot CJ, Ahn YS. Endothelial microparticles (EMP) as vascular disease markers. Adv Clin Chem. 2005;39:131–157. Cerca con Google

15. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, TanakaT, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;45:1622– 1630. Cerca con Google

16. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J,London GM, Tedgui A, Boulanger CM. Circulating endothelial microparticlesare associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16:3381–3388. Cerca con Google

17. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7. Cerca con Google

18. Masataka Sata. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension. Lessons from animal models. Artheriosclerosis Thromb Vasc Biol 2006;26:1008-1014. Cerca con Google

19. N Nagaya, K kangawa, M Kanda et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003;108:889-895. Cerca con Google

20. Wang XX, Zhang FR and Shang YP et al. Trasplantation of autologous endothelial progenitor cell may be benefical in patients with idiopathic pulmonary arterial hypertension. JACC 2007;491566-71. Cerca con Google

21. BarstRJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:40-7. Cerca con Google

22. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G et al. Clinical classification of pulmonary hypertension.J Am Coll Cardiol 2004;43:5-12. Cerca con Google

23. G Pietra, F Capron, S Stewart, O Leone, M Humbert, IM Robbins et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:24-32. Cerca con Google

24. Martin KB, Klinger JR and SIS Rounds. Pulmonary arterial hypertension: new insighst and new hope. Respirology 2006; 11:6-17. Cerca con Google

25. N Galié, W Seeger, R Naeije, G Simonneau, LJ Rubin. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:81-88. Cerca con Google

26. Korbling M, Estrov Z. Adult stem cells for tissue repair – a new therapeutic consept? N Engl J Med 2003;349:570-82.27. Cerca con Google

27. Korbling M, Estrov Z, Champlin R. Adult stem cells and tissue repair. Bone Marrow Transplant 2003;32(1):S23-4. Cerca con Google

28. Carmeliet P. Developmental biology: One cell, two fates. Nature 2000;408:43-45. Cerca con Google

29. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-9. Cerca con Google

30. Liu C, Nath KA, Katusic ZS, et al. Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med 2004;14:288-93. Cerca con Google

31. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-6. Cerca con Google

32. Stump MM, Jordan GL, Debakay ME, et al. Endothelium grown from circulating blood on isolated intravascular Dacron Hub. Am J Pathol 1963;43:361-367. Cerca con Google

33. Zammaretti P, Zisch, Andreas H. Adult endothelial progenitor cells: Renewing vasculature. The International Journal of Biochemistry and Cell Biology 2005;37:493-503. Cerca con Google

34. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-7. Cerca con Google

35. Ferrario M, Massa M, Rosti V et al. Early haemoglobinindependent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J. 2007 28:1805-13. Cerca con Google

36. Xu Q. The role of stem cells in atherosclerosis. Arch Mal Coeur Vaiss. 2005;98:672-6.ù Cerca con Google

37. Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 2005;67:1672- 6. Cerca con Google

38. Hillebrands JL, Onuta G, Rozing J.Role of progenitor cells in transplant arteriosclerosis. Trends Cardiovasc Med. 2005;15:1-8. Cerca con Google

39. Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95:911-21. Cerca con Google

40. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003 Aug 15;102:1340-6. Cerca con Google

41. Lu SJ, Feng Q, Caballero S et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods. 2007;4:501-9. Cerca con Google

42. Rosenzweig A. Circulating endothelial progenitors--cells as biomarkers. N Engl J Med. 2005;353(10):1055-7. Cerca con Google

43. Leor J, Marber M. Endothelial progenitors: a new Tower of Babel? J Am Coll Cardiol. 2006; 48(8):1588-90. Cerca con Google

44. Uzan G. Therapeutic potential of circulating endothelial cells. J Soc Biol. 2005;199:107-11. Cerca con Google

45. Kocher AA, Schuster MD, Bonaros N et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol. 2006;40:455-64. Cerca con Google

46. Dignat-George F, Sampol J, Lip G, Blann AD. Circulating endothelial cells: realities and promises in vascular disorders. Pathophysiol Haemost Thromb. 2003;33:495-9. Cerca con Google

47. Qin G, Ii M, Silver M, Wecker A et al. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med. 2006 ;203153-63. Cerca con Google

48. Wojakowski W, Tendera M. Mobilization of bone marrowderived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol. 2005;43229-32. Cerca con Google

49. Romagnani P, Annunziato F, Liotta F et al.CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors.Circ Res. 2005 ;97:314-22. Cerca con Google

50. Galli D, Innocenzi A, Staszewsky L et al. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:692-7. Cerca con Google

51. Bonafè F, Muscari C, Guarnieri C, Caldarera CM. Regeneration of infarcted cardiac tissue: the route of stem cells. Ital Heart J Suppl. 2003;4:299-305. Cerca con Google

52. Schwartzenberg S, Deutsch V, Maysel-Auslender S et al. Circulating apoptotic progenitor cells: a novel biomarker in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2007 ;27:27-31. Cerca con Google

53. Schillaci G, Pirro M. Endothelial microparticles and arterial stiffness: casual coincidence or causative culprit? Am J Hypertens. 2007;20:965-6. Cerca con Google

54. Wang JM, Huang YJ, Wang Y et al. Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens. 2007 ;20:957-64. Cerca con Google

55. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol. 2007;66:159-65. Cerca con Google

56. Lacroix R, Sabatier F, Mialhe A et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007;110:2432-9. Cerca con Google

57. Chironi G, Simon A, Hugel B et al. Circulating leukocytederived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol. 2006;26:2775-80. Cerca con Google

58. Morel O, Toti F, Hugel B et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006;26:2594-604. Cerca con Google

59. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.Hypertension 2006;48:180-6. Cerca con Google

60. Baird AE, Wright VL.Vascular biology: cellular and molecular profiling. Semin Neurol. 2006;26:65-74. Cerca con Google

61. Tan KT, Lip GY.The potential role of platelet microparticles in atherosclerosis. Thromb Haemost. 2005;94:488-92. Cerca con Google

62. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 2003;13:249-53. Cerca con Google

63. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001;88:167-74. Cerca con Google

64. Martínez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function.Am J Physiol Heart Circ Physiol. 2005;288:H1004-9. Cerca con Google

65. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004;44:2293- 300. Cerca con Google

66. Héloire F, Weill B, Weber S, Batteux F. Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction.Thromb Res. 2003;110:173-80. Cerca con Google

67. Pirro M, Schillaci G, Bagaglia F., Mannarino E, et al. Increased Ratio of CD31+/CD42- Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2530-5. Epub 2006 Aug 31. Cerca con Google

68. Goon PKY, Lip GYH, Boos CJ, Stonelake PS, Blann AD. Circulating endothelial cells, endothelial progenitor cells and endothelial microparticles in cancer. Neoplasia 2006;8:79-88. Cerca con Google

69. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstmann LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175–180. Cerca con Google

70. Combes V, Simon A, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93–102. Cerca con Google

71. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 1996:3245–3254. Cerca con Google

72. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood reviews 2006 (in press). Cerca con Google

73. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003;1:1655–1662. Cerca con Google

74. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9 and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002;160:673– 680. Cerca con Google

75. Casciola-Rosen L, Rosen A, Petri M, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Nat Acad Sci USA 1996;93:1624–1629. Cerca con Google

76. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102:2678–2683. Cerca con Google

77. Jimenez JJ, Jy W, Mauro LM, Horstmann LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopaenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003;123:896–902. Cerca con Google

78. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649–2652. Cerca con Google

79. Classificazione delle malattie, traumatismi e cause di morte. Xa revisione, 2002. Istituto Poligrafico dello Stato. 80. S. Provencher, S. Martel, X Jais, O Sitbon, M. Humbert, G. Simonneau. Diagnostic et classification des hypertensions arteriélles pulmonaires. Pneumologie 2005;2:192-203. Cerca con Google

80. S. Provencher, S. Martel, X Jais, O Sitbon, M. Humbert, G. Simonneau. Diagnostic et classification des hypertensions arteriélles pulmonaires. Pneumologie 2005;2:192-203. Cerca con Google

81. S Sciomer, R Badagliaca, F Fedele. Pulmonary Hypertension: echocardiographic assessment. Italian Heart Journal 2005 Ottobre;6:840-845. Cerca con Google

82. N Gallié, A Manes, A Branzi. Evaluation of Pulmonary arterial Hypertension. Italian Heart Journal 2005 Ottobre;6:575-581. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record